170 related articles for article (PubMed ID: 20022344)
41. [Transverse relaxation time of metabolites by proton MRS: one of the parameters concerned with quantification].
Harada M; Miyoshi H; Otsuka H; Taoka Y; Nishitani H
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 May; 57(6):350-2. PubMed ID: 9194368
[TBL] [Abstract][Full Text] [Related]
42. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.
Videen JS; Michaelis T; Pinto P; Ross BD
J Clin Invest; 1995 Feb; 95(2):788-93. PubMed ID: 7860762
[TBL] [Abstract][Full Text] [Related]
43. Proton magnetic resonance spectroscopy and its diagnostically important metabolites in the brain.
Bittšanský M; Výbohová D; Dobrota D
Gen Physiol Biophys; 2012 Mar; 31(1):101-12. PubMed ID: 22447836
[TBL] [Abstract][Full Text] [Related]
44. Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.
Al-Iedani O; Arm J; Ribbons K; Lea R; Lechner-Scott J; Ramadan S
Eur J Radiol; 2018 Nov; 108():107-113. PubMed ID: 30396641
[TBL] [Abstract][Full Text] [Related]
45. Gender-dependent behavioural impairment and brain metabolites in young adult rats after short term exposure to lead acetate.
Mansouri MT; Naghizadeh B; López-Larrubia P; Cauli O
Toxicol Lett; 2012 Apr; 210(1):15-23. PubMed ID: 22285975
[TBL] [Abstract][Full Text] [Related]
46. Diurnal variability of cerebral metabolites in healthy human brain with 2D localized correlation spectroscopy (2D L-COSY).
Arm J; Al-Iedani O; Lea R; Lechner-Scott J; Ramadan S
J Magn Reson Imaging; 2019 Aug; 50(2):592-601. PubMed ID: 30629765
[TBL] [Abstract][Full Text] [Related]
47. The impact of blood pressure on hippocampal glutamate and mnestic function.
Westhoff TH; Schubert F; Wirth C; Joppke M; Klär AA; Zidek W; Gallinat J
J Hum Hypertens; 2011 Apr; 25(4):256-61. PubMed ID: 20463749
[TBL] [Abstract][Full Text] [Related]
48. Neonatal hydrocortisone treatment related to 1H-MRS of the hippocampus and short-term memory at school age in preterm born children.
Rademaker KJ; Rijpert M; Uiterwaal CS; Lieftink AF; van Bel F; Grobbee DE; de Vries LS; Groenendaal F
Pediatr Res; 2006 Feb; 59(2):309-13. PubMed ID: 16439598
[TBL] [Abstract][Full Text] [Related]
49. Metabolic changes in the thalamus after spinal cord injury followed by proton MR spectroscopy.
Likavcanová K; Urdzíková L; Hájek M; Syková E
Magn Reson Med; 2008 Mar; 59(3):499-506. PubMed ID: 18219631
[TBL] [Abstract][Full Text] [Related]
50. Time course of early metabolic changes following diffuse traumatic brain injury in rats as detected by (1)H NMR spectroscopy.
Pascual JM; Solivera J; Prieto R; Barrios L; López-Larrubia P; Cerdán S; Roda JM
J Neurotrauma; 2007 Jun; 24(6):944-59. PubMed ID: 17600512
[TBL] [Abstract][Full Text] [Related]
51. Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers.
Bolo N; Nédélec JF; Muzet M; De Witte P; Dahchour A; Durbin P; Macher JP
Psychiatry Res; 1998 May; 82(2):115-27. PubMed ID: 9754454
[TBL] [Abstract][Full Text] [Related]
52. MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.
Tunc-Skarka N; Weber-Fahr W; Hoerst M; Meyer-Lindenberg A; Zink M; Ende G
Neuroimage; 2009 Nov; 48(3):525-31. PubMed ID: 19573608
[TBL] [Abstract][Full Text] [Related]
53. Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus.
Weisskopf MG; Hu H; Sparrow D; Lenkinski RE; Wright RO
Environ Health Perspect; 2007 Apr; 115(4):519-23. PubMed ID: 17450218
[TBL] [Abstract][Full Text] [Related]
54. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.
Hattori N; Abe K; Sakoda S; Sawada T
Neuroreport; 2002 Jan; 13(1):183-6. PubMed ID: 11924885
[TBL] [Abstract][Full Text] [Related]
55. (1)H MR spectroscopy in pediatrics.
Dezortova M; Hajek M
Eur J Radiol; 2008 Aug; 67(2):240-249. PubMed ID: 18423936
[TBL] [Abstract][Full Text] [Related]
56. Magnetization transfer attenuation of creatine resonances in localized proton MRS of human brain in vivo.
Helms G; Frahm J
NMR Biomed; 1999 Dec; 12(8):490-4. PubMed ID: 10668041
[TBL] [Abstract][Full Text] [Related]
57. In vivo proton magnetic resonance spectroscopic examination of benzodiazepine action in humans.
Yildiz A; Gökmen N; Kücükgüclü S; Yurt A; Olson D; Rouse ED; Moore C; Dicle O; Renshaw PF
Psychiatry Res; 2010 Dec; 184(3):162-70. PubMed ID: 21036017
[TBL] [Abstract][Full Text] [Related]
58. Localized proton MRS of cerebral metabolite profiles in different mouse strains.
Schwarcz A; Natt O; Watanabe T; Boretius S; Frahm J; Michaelis T
Magn Reson Med; 2003 May; 49(5):822-7. PubMed ID: 12704764
[TBL] [Abstract][Full Text] [Related]
59. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.
Sibbitt WL; Haseler LJ; Griffey RH; Hart BL; Sibbitt RR; Matwiyoff NA
AJNR Am J Neuroradiol; 1994 May; 15(5):923-8. PubMed ID: 8059662
[TBL] [Abstract][Full Text] [Related]
60. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
Abbott C; Bustillo J
Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
